Requirement of Mammalian Timeless for Circadian Rhythmicity

Science

Volumn 302, Issue 5644, 2003, Pages 439-442

  Barnes, Jessica W ^a   Tischkau, Shelley A ^a,b   Barnes, Jeffrey A ^a   Mitchell, Jennifer W ^a   Burgoon, Penny W ^a   Hickok, Jason R ^a   Gillette, Martha U ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NATURAL SCIENCES; NEUROLOGY; PROTEINS;

PROTEIN EXPRESSION;

BIODIVERSITY;

MPER PROTEIN; MTIM PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CIRCADIAN RHYTHM; DROSOPHILA; MAMMAL; NEGATIVE FEEDBACK; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPRACHIASMATIC NUCLEUS; TRANSCRIPTION REGULATION;

ANIMALS; BIOLOGICAL CLOCKS; CELL CYCLE PROTEINS; CELL LINE; CIRCADIAN RHYTHM; DROSOPHILA PROTEINS; ELECTROPHYSIOLOGY; EYE PROTEINS; FLAVOPROTEINS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEURONS; NUCLEAR PROTEINS; OLIGONUCLEOTIDES, ANTISENSE; PHOTORECEPTORS, INVERTEBRATE; RATS; RATS, INBRED STRAINS; RECEPTORS, G-PROTEIN-COUPLED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; SUPRACHIASMATIC NUCLEUS; TRANSCRIPTION FACTORS; TRANSFECTION;

MAMMALIA;

EID: 0142052946     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1086593     Document Type: Article

References (26)

1. J. C. Dunlap. Cell 96, 271 (1999).
2. M. W. Young, S. A. Kay, Nature Rev. Genet. 2, 702 (2001).
3. D. P. King, J. S. Takahashi, Annu. Rev. Neurosci. 23, 713 (2000).
4. A. Sehgal, J. L. Price, B. Man, M. W. Young, Science 263, 1603 (1994).
5. M. D. Fietd et al., Neuron 25, 437 (2000).
6. A. L. Gotter et al., Nature Neurosci. 3, 755 (2000).
7. E. A. Griffin Jr., D. Staknis, C. J. Weitz, Science 286, 768 (1999).
8. N. Koike et al., FEBS Lett. 441, 427 (1998).
9. K. Kume et al., Cell 98, 193 (1999).
10. S. Sakamoto et al., Biochem. Biophys. Res. Commun. 279, 131 (2000).
11. A. M. Sangoram et al., Neuron 21, 1101 (1998).
12. T. Takumi et al., Genes Cells 4, 67 (1999).
13. S. A. Tischkau et al., J. Neurosci. 19, RC15 (1999).
14. M. J. Zylka et al., Neuron 21, 1115 (1998).
15. U. Albrecht, J. Appl. Physiol. 92, 1348 (2002).
16. Z. Li et al., Proc. Natl. Acad. Sci. U.S.A. 97, 10038 (2000).
17. M. Akiyama et al., J. Neurosci. 19, 1115 (1999).
18. S. A. Tischkau, J. W. Mitchell, S. H. Tyan, G. F. Buchanan, M. U. Gillette, J. Biol. Chem. 278, 718 (2003).
19. H. Wakamatsu et al., Neuroreport 12, 127 (2001).
20. L. M. Gerhold, M. T. Sellix, M. E. Freeman, J. Comp. Neurol. 450, 135 (2002).
21. J. P. Harney, K. Scarbrough, K. L. Rosewell, P. M. Wise, Endocrinology 137, 3696 (1996).
22. Materials and methods are available as supporting material on Science Online.
23. M. H. Hastings, M. D. Field, E. S. Maywood, D. R. Weaver, S. M. Reppert, J. Neurosci. 19, RC11 (1999).
24. D. J. Earnest, F. Q. Liang, M. Ratcliff, V. M. Cassone, Science 283, 693 (1999).
25. J. L. Price, M. E. Dembinska, M. W. Young, M. Rosbash, EMBO J. 14, 4044 (1995).
26. The authors thank L. Levesque for her generous gift of TAP antiserum. Supported by Public Health Service Grants NS22155, NS35859, HL67007, and a University Scholar award (M.U.G.); GM07143 (J.W.B., J.A.B.); NS10170 (S.A.T.); NS11158 (J.W.M.); N511134 (P.W.B.); and a grant from the Illinois Governor's Venture Technology Fund/Molecular & Endocrine Pharmacology Program (S.A.T.). Opinions, findings, and conclusions or recommendations expressed herein are those of the authors and do not necessarily reflect the views of funding agencies.